(2R)-2-AMINO-3,3,3-TRIFLUOROPROPAN-1-OL HCL, 95.0%, 1g

2-(4-ETHYL-3-IODOPHENYL)-2-METHYLPROPANOIC ACID, 95.0%, 10g

(R)-1-N-Boc-3-Cyanopiperazine, 95.0%, 5g

3-(tert-Butyl)-4-hydroxybenzonitrile, 95.0%, 10g

Telmisartan>98.0%(HPLC)(T)5g

2-Ethylcyclohexanol (cis- and trans- mixture)>97.0%(GC)100mL

N-[(3S)-Pyrrolidin-3-yl]-6-(trifluoromethyl)-pyrimidin-4-amine dihydrochloride, 1g

1-(2,5-Dichlorophenyl)cyclopentan-1-amine, 95%, 250mg

ethyl 5-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-5-oxovalerate, 97.0%, 1g

(2R,3R,4S,5S)-2-(6-Amino-9H-purin-9-yl)-5-((methylthio)methyl)tetrahydrofuran-3,4-diol, 95.0%, 250mg

(R)-tert-Butyl (1-(4-bromophenyl)-2-hydroxyethyl)carbamate, 97.0%, 10g

2-chloro-4-isopropyl-1,3-benzothiazole, 95.0%, 250mg

3-(Oxiran-2-ylmethoxy)benzaldehyde, 97.0%, 100mg